84 results
8-K
EX-1.1
VBIVQ
VBI Vaccines Inc
15 May 24
VBI Vaccines Reports First Quarter 2024 Financial Results
4:18pm
of this Agreement shall mean any action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding … or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
8-K
EX-5.1
VBIVQ
VBI Vaccines Inc
15 May 24
VBI Vaccines Reports First Quarter 2024 Financial Results
4:18pm
of the Company and of public officials. We have not undertaken any independent investigation to verify the accuracy or completeness of any of the foregoing
8-K
EX-5.1
trw hcgjfmib1jj
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
8-K
EX-10.1
tw9os8b 1vr7e
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
8-K
EX-5.2
ue6b3wjt
11 Jul 23
Other Events
4:05pm
8-K
EX-5.1
0cthq
11 Jul 23
Other Events
4:05pm
8-K
EX-4.1
xpj5cl
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
8-K
EX-1.1
m30i42jx
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
8-K
EX-10.1
3sxvblwvarrwq
5 Jul 23
Entry into a Material Definitive Agreement
4:17pm